
Mankind Pharma Limited
Mankind Pharma Limited is an India-based company in the Healthcare sector with a market capitalisation of $9.8B. Its FinScore is 62/100; its highest-scoring layer is Quality (75) and its lowest is Value (40). The shares trade at 46.0x trailing earnings and are up 5% year to date.
Share price performance
About Mankind Pharma Limited
www.mankindpharma.comMankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- India
- Fiscal year-end
- March
- Trading currency
- INR
- Reporting currency
- INR
- Fundamentals updated
- 65 days ago
- Market cap
- $9.8B
- Shares outstanding
- 413.0M
- P/E (TTM)
- 46.0x
- Beta (issuer)
- 0.45
- Revenue (latest FY)
- ₹142.8B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.